ReviewCancer immunology, immunotherapy : CII2011

The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy.

Anna Maria Berghella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.